For the time being we are hosting Virtual Thursday Gatherings!Learn more here!
Join our Virtual Thursday Gatherings!


Loading Events

« All Events

  • This event has passed.

Break Out: Disposable point of care biochip platform – Enzyre B.V.

November 8, 2018, 18:30 - 19:30

Point of Care diagnostics is becoming more popular as it will help patients in the management of their disease. Enzyre has obtained proof of principle to measure multiple enzymatic parameters in just a few drops of blood collected by the patient. This platform can help managing a wide variety of complex diseases. Several international collaborations have been established between Enzyre and semi-conductor, microfluidic and pharmaceutical companies.

Enzyre’s first activities are focused on coagulation diseases to prevent patients bleeding to death. In total, three business cases have been identified in the area of blood coagulation: hemophilia treatment management, hemodynamic monitoring in the critical care setting and management of oral anti-coagulant monitoring.

Enzyre’s biochip provides a full picture of someone’s coagulation status including existing standard of care assays and new global assays depicting coagulation potential and improved safety. As such, there is significant interest form big pharma for our technology.
This platform can help managing a wide variety of complex diseases.

Enzyre BV is located at the Novio Tech Campus (Nijmegen, The Netherlands). Currently, the team exists of an experienced of a solid scientific team of seven people with more than 50 years’ experience in coagulation and pharmaceutical research under supervision of Waander van Heerde, CSO.

Details

Date:
November 8, 2018
Time:
18:30 - 19:30
Event Tags:
, ,